Quality of Life Assessment of Chronic Pancreatitis Endoscopic Interventions

This is a multicenter prospective cohort study assessing the impact of endoscopic
interventions on patients with chronic pancreatitis. Patients with chronic pancreatitis
referred for endoscopic treatment, including pancreatic duct dilation and stenting,
pseudocyst drainage, celiac plexus blocks, and pseudocyst drainage/necrosectomy will be
enrolled in this study. They will receive a baseline evaluation using the PANQOLI, a chronic
pancreatitis-specific quality of life instrument, in addition to a visual analog scale to
measure their pain. Demographic and endoscopic features will be collected in addition to pain
medication use. Patients will receive follow-up at 1, 3, and 6 months post-intervention
consisting of the PANQOLI, visual analog scale for pain, and pain medication use.

Inclusion Criteria:

- Patients with painful chronic pancreatitis, defined as either 1) the presence of
pancreatic calcifications on cross-sectional imaging, 2) morphologic changes
consistent with the Rosemont criteria on endoscopic ultrasound, or 3) endoscopic
pancreatic function test results consistent with decreased pancreatic function.

Exclusion Criteria:

- Pregnant females

- Prisoners

- Patients under the age of 18

- Patients lacking the capacity to consent